Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Analytical Chemistry
|
October 13, 2020
Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues
Naiyu Zheng, Kristin Taylor, Huidong Gu, et al.
Bioanalysis
|
November 30, 2010
Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma
Anne-Françoise Aubry, Huidong Gu, Reynald Magnier, et al.
Analytical Chemistry
|
October 31, 2012
Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay
Hao Jiang, Jianing Zeng, Wenying Li, et al.
The AAPS Journal
|
May 9, 2022
Biomarker Assay Validation by Mass Spectrometry
Carmen Fernández-Metzler, Brad Ackermann, Fabio Garofolo, et al.
Analytical Chemistry
|
May 1, 2012
Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies
Huidong Gu, Jian Wang, Anne-Françoise Aubry, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 28, 2015
Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC-MS/MS approach: Assay development, validation, and a case study
Ang Liu, Alexander Kozhich, David Passmore, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations
Xiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Clinical Pharmacokinetics
|
September 29, 2012
A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects
Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, et al.
Clinical Drug Investigation
|
September 29, 2012
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men
Gary Tong, Lorna Castaneda, Jun-Sheng Wang, et al.
British Journal of Clinical Pharmacology
|
May 24, 2012
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Analytical Chemistry
|
October 13, 2020
Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues
Naiyu Zheng, Kristin Taylor, Huidong Gu, et al.
Bioanalysis
|
November 30, 2010
Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma
Anne-Françoise Aubry, Huidong Gu, Reynald Magnier, et al.
Analytical Chemistry
|
October 31, 2012
Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay
Hao Jiang, Jianing Zeng, Wenying Li, et al.
The AAPS Journal
|
May 9, 2022
Biomarker Assay Validation by Mass Spectrometry
Carmen Fernández-Metzler, Brad Ackermann, Fabio Garofolo, et al.
Analytical Chemistry
|
May 1, 2012
Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies
Huidong Gu, Jian Wang, Anne-Françoise Aubry, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 28, 2015
Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC-MS/MS approach: Assay development, validation, and a case study
Ang Liu, Alexander Kozhich, David Passmore, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations
Xiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Clinical Pharmacokinetics
|
September 29, 2012
A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects
Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, et al.
Clinical Drug Investigation
|
September 29, 2012
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men
Gary Tong, Lorna Castaneda, Jun-Sheng Wang, et al.
British Journal of Clinical Pharmacology
|
May 24, 2012
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Page
of 4